Surfactant therapy in the USA: Trials and current routines

Biology of the Neonate

Volumn 71, Issue SUPPL. 1, 1997, Pages 1-7

  Soll, Roger F ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; LUNG SURFACTANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; ENDOTRACHEAL TUBE; HUMAN; LUNG DYSPLASIA; META ANALYSIS; NEWBORN; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PULMONARY SURFACTANTS; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; UNITED STATES;

ANIMALIA;

EID: 0030982365     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Soll RF, McQueen MC: Respiratory distress syndrome; in Sinclair JC, Bracken MB (eds): Effective Care of the Newborn, London, Oxford University Press, 1992, pp 325-358.
2. Jobe AH: Pulmonary surfactant therapy. N Engl J Med 1993;328: 861-868.
3. The Investigators of the Vermont Oxford Trials Network Database Project: The Vermont-Oxford Trials Network: Very Low Birthweight outcomes for 1990. Pediatrics 1993; 91:540-545.
4. Horbar JD, Wright EC, Onstad L, and the Members of the National Institute of Child Health and Human Development Neonatal Research Network: Decreasing mortality associated with the introduction of surfactant therapy: An observational study of neonates weighing 601-1,300 grams at birth. Pediatrics 1993;92:191-196.
5. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ: Effect of surfactant on morbidity, mortality and resource use in newborn infants weighing 500-1,500 gms. N Engl J Med 1994;330:1476-1480.
6. Curstedt T, Jörnvall H, Robertson B, Bergman T, Berggren P: The hydrophobic low molecular mass protein fractions of pulmonary surfactant: characterization and biophysical activity. Eur J Biochem 1987; 168:255-262.
7. Possmayer F: The role of surfactant associated proteins. Am Rev Respir Dis 1990;142:749-752.
8. Tooley WH, Clements JA, Muramatsu K, Brown CL, Schlueter MA: Lung function in prematurely delivered rabbits treated with a synthetic surfactant. Am Rev Respir Dis 1987;136:651-656.
9. Alvarado M, Hingre R, Hakanson D, Gross S: Clinical trial of Survanta versus Exosurf in infants < 1500 g with respiratory distress syndrome. Pediatr Res 1993;33:314A.
10. Horbar JD, Wright LL, Soll RF, Wright EC, Fanaroff AA, Korones SB, Shankaran S, Oh W, Fletcher BD, Bauer CR, Tyson JE, Lemons JA, Donovan EF, Stoll BJ, Stevenson DD, Papile L-A, Phillips III J, for the National Institute of Child Health and Human Development Neonatal Research Network: A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993;123:757-766.
11. Hudak ML, Farrell EE, Rosenberg AA, Jung AL, Auten RL, Durand DJ, Horgan MJ, Buchwald S, Belcastro MR, Donohue PK, Carrion V, Maniscalco WW, Balsan MJ, Torres BA, Miller RR, Jansen RD, Graeber JE, Laskay KM, Matteson EJ, Egan EA, Brody AS, Martin DJ, Riddlesberger MM, Mongomery P: A multicenter randomized masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr 1996;128:396-406.
12. Mondanlou H, Beharry K, Norris K, Bottoli I, Aranda JV: Comparative effects of Survanta (Surv) and Exosurf (Exo) on the outcome of respiratory distress syndrome (RDS). Pediatr Res 1994;35:242A.
13. Pearlman SA, Leef KH, Stefano JL, Spear ML, Esterly KL: A randomized trial comparing Exosurf versus Survanta in the treatment of neonatal RDS. Pediatr Res 1993;33: 340A.
14. The Vermont Oxford Neonatal Network: A multicenter randomized: trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 1996;97:1-6.
15. Soll RF: Natural surfactant extract vs. synthetic surfactant in the treatment of respiratory distress syndrome. Submitted to The Cochrane Database of Systematic Reviews.
16. Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW, Kheither A: Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant Rhesus monkeys. Pediatr Res 1996; 39:715-724.
17. 4 surfactant in preterm infants with respiratory distress syndrome. Am J Respir Crit Care Med 1996;153:404-410.
18. Zola EM, Gunkel JH, Chan RK, Lim MO, Knox I, Feldman BH, Denson SE, Stonestreet BS, Mitchell BR, Wyza MM, et al: Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome. J Pediatr 1993;122:453-459.
19. Ueda T, Ikegami M, Rider ED, Jobe AH: Distribution of surfactant and ventilation in surfactant treated preterm lambs. J Appl Physiol 1994;76: 45-55.
20. Lewis JF, Tabor B, Ikegami M, Jobe AH, Joseph M, Absolom D: Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol 1993;74:1256-1264.
21. Nilsson R, Grossmann G, Robertson B: Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artifical ventilation. Pediatr Res 1978;12:249-255.
22. Jobe A, Ikegami M: Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 1987;136:1256-1275.
23. Dunn MS, Shennan AT, Zyack D, Possmayer F: Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: A randomized controlled trial of prophylaxis vs treatment. Pediatrics 1991; 87:377-386.
24. Egberts J, de Winter JP, Sedin G, de Kleine MJK, Broberger U, van Bel F, Curstedt T, Robertson B: Comparison of prohylaxis and rescue treatment with Curosurf in babies less than 30 weeks gestation. Pediatrics 1993;92:768-774.
25. Kattwinkel J, Bloom BT, Delmore P, Davis CL, Farrell E, Friss H, Jung AL, King K, Mueller D: Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestations. Pediatrics 1993;92:1-9.
26. Kendig JW, Notter RH, Cox C, Reubens LJ, Davis JM, Maniscalco WM, Sinkin RA, Bartoletti A, Dweck HS, Horgan MJ, Risemberg H, Phelps DL, Shapiro DL: A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med 1991;324:865-871.
27. Merritt TA, Hallman M, Berry C, Pohjavuori M, Edwards III DK, Jaaskelainen J, Grafe MR, Vaucher Y, Wozniak P, Heldt G, Rapola J: Randomized, placebo-controlled trial of human surfactant given at birth vs rescue administration in very low birthweight infants with lung immaturity. J Pediatr 1991;118:581-594.
28. Walti H, Paris-Uado J, Breart G, Couchard M: Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: A randomized multicentre trial of prophylaxis versus rescue with multiple low doses. Acta Paediatr 1995;84:913-921.
29. Bevilacqua G, Parmigiani S, Robertson B and the Italian Collaborative Multicenter Group: Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicenter prospective randomized trial. J Perinat Med 1996;24:609-620.
30. Soll RF: Prophylactic surfactant vs. treatment with surfactant. Submitted to The Cochrane Database of Systematic Reviews.
31. Dunn MS, Shennan AT, Possmayer F: Single- versus multiple-dose surfactant replacement therapy in neonates at 30 to 36 weeks gestation with respiratory distress syndrome. Pediatrics 1990;86:564-571.
32. Speer CP, Robertson B, Curstedt T, Halliday HL, Compagnone D, Gefeller O, Harms K, Herting E, McClure G, Reid M, Tubman R, Herin P, Noack G, Kok J, Koppe J, van Sonderen L, Laufkötter E, Köhler W, Boenisch H, Albrecht K, Hanssler L, Haim M, Oetomo SB, Okken A, Altfeld PC, Groneck P, Kachel W, Relier J-P, Walti H: Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: Single versus multiple doses of Curosurf. Pediatrics 1992;89:13-20.
33. Soll RF: Multiple vs single dose surfactant therapy. Submitted to The Cochrane Database of Systematic Reviews.
34. OSIRIS Collaborative Group: Early versus delayed neonatal administration of a synthetic surfactant: The judgement of OSIRIS. Lancet 1992; 340:1363-1369.
35. Zola EM, Overbach AM, Gunkel JH, Mitchell BR, Nagle BT, DeMarco NO, Henwood GA, Gold AJ: Treatment investigational new drug experience with Survanta (Beractant). Pediatrics 1993;91:546-551.
36. Sun B, Curstedt T, Robertson B: Surfactant intubation in experimental meconium aspiration. Acta Paediatr 1993;82:182-189.
37. Sun B, Curstedt T, Song G-W, Robertson B: Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration. Biol Neonate 1993;63:96-104.
38. Findlay RD, Taeusch HW, Walther FJ: Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996;97:48-52.
39. Lotze A, and The Survanta in Term Infants Study Group: Survanta Pre-ECMO Trial: multicenter evaluation of Survanta in treatment of term infants with severe respiratory failure. Pediatr Res 1996;39:226A